These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12242758)

  • 21. National Institute for Clinical Excellence and its value judgments.
    Rawlins MD; Culyer AJ
    BMJ; 2004 Jul; 329(7459):224-7. PubMed ID: 15271836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raise the Voice! Transforming America's health care system through nursing solutions.
    Bolton LB
    Nurs Outlook; 2007; 55(1):3-4. PubMed ID: 17289461
    [No Abstract]   [Full Text] [Related]  

  • 23. The NICE process for developing quality standards and indicators.
    Bennett B; Coventry E; Greenway N; Minchin M
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(8-9):481-6. PubMed ID: 25523846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The National Institute for Health and Clinical Excellence and its role in assessing the value of new cancer treatments in England and Wales.
    Trowman R; Chung H; Longson C; Littlejohns P; Clark P
    Clin Cancer Res; 2011 Aug; 17(15):4930-5. PubMed ID: 21791636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WIN: 50 years of nursing research and counting.
    Heitkemper MM
    Commun Nurs Res; 2007; 40():57-64. PubMed ID: 17900067
    [No Abstract]   [Full Text] [Related]  

  • 26. The HSJ interview: Andrew Dillon. The NICE guy. Interview by Lyn Whitfield.
    Dillon A
    Health Serv J; 2003 Jun; 113(5858):20-1. PubMed ID: 12808869
    [No Abstract]   [Full Text] [Related]  

  • 27. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
    Birch S; Gafni A
    Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
    [No Abstract]   [Full Text] [Related]  

  • 28. Health technology assessment for the NHS in England and Wales.
    Woods K
    Int J Technol Assess Health Care; 2002; 18(2):161-5. PubMed ID: 12053415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Something 'nice' can come out of this.
    Weiner JP
    Manag Care; 2002 Jan; 11(1):30, 32. PubMed ID: 11828872
    [No Abstract]   [Full Text] [Related]  

  • 30. A statewide strategy for nursing workforce development through partnerships in Texas.
    Kishi A; Green A
    Policy Polit Nurs Pract; 2008 Aug; 9(3):210-4. PubMed ID: 18515787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cancer technology appraisal programme of the UK's National Institute for Clinical Excellence.
    Littlejohns P; Barnett D; Longson C;
    Lancet Oncol; 2003 Apr; 4(4):242-50. PubMed ID: 12681268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can technology improve intershift report? What the research reveals.
    Strople B; Ottani P
    J Prof Nurs; 2006; 22(3):197-204. PubMed ID: 16759963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining the implementation of NICE guidance: cross-sectional survey of the use of NICE interventional procedures guidance by NHS Trusts.
    Lowson K; Jenks M; Filby A; Carr L; Campbell B; Powell J
    Implement Sci; 2015 Jun; 10():93. PubMed ID: 26122560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health technology assessment in England and Wales.
    Stevens A; Milne R
    Int J Technol Assess Health Care; 2004; 20(1):11-24. PubMed ID: 15176173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blues pitches institute. Some question insurer-paid efficacy research.
    Conn J
    Mod Healthc; 2007 May; 37(20):8-9. PubMed ID: 17546752
    [No Abstract]   [Full Text] [Related]  

  • 36. The National Institute for Clinical Excellence and its relevance to pharmacology.
    Kerwin R
    Trends Pharmacol Sci; 2004 Jul; 25(7):346-8. PubMed ID: 15219972
    [No Abstract]   [Full Text] [Related]  

  • 37. NICE and LICE: lessons from a health district. National Institute for Clinical Excellence. Local institutes of clinical excellence.
    Madhok R; Taylor A; Soltani H; Ireland K
    J Public Health Med; 2002 Mar; 24(1):2-5. PubMed ID: 11939377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Institute for Health and Care Excellence.
    Cowie MR
    Eur Heart J; 2015 Jan; 36(4):195. PubMed ID: 25756143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.